Definitive Contract 75F40122C00082
Award Date
7/12/22
Potential Completion Date
1/14/28
Potential Value
$365K
Federal Agency
Food and Drug Administration
Ultimate Awardee
State Of Utah
NAICS Category
923120 - Administration of Public Health Programs
PSC Category
H265 - Equipment And Materials Testing- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84114, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the State of Utah Department of Environmental Quality, a U.S. state government entity, for UTAH MQSA INSPECTIONS. The contract is a firm fixed-price contract with a potential value of $279,014.00. The place of performance is Salt Lake City, Utah. No set-aside designation is mentioned. The State of Utah Department of Environmental Quality has experience providing a variety of...
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...
This is a definitive contract awarded by the U.S. Food and Drug Administration (FDA) to The Environment Maryland Department Of Office Of Fiscal Services Division, doing business as State Of Maryland, for $705,383.99. The contract is for Mammography Quality Standards Act (MQSA) inspections and does not have a set-aside designation. As the state environmental protection agency, The Environment Maryland Department is responsible for various environmental programs, monitoring activities, and...
The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price definitive contract valued at $650,130.35 to the New Mexico Environment Department (NMED), a U.S. state government entity, to provide Mammography Quality Standards Act (MQSA) inspection services in Santa Fe, New Mexico. The contract has an ultimate completion date of January 14, 2028. NMED, as a state agency, does not have a set-aside designation for this award. NMED has extensive experience conducting regulatory...
This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to the Connecticut Department of Energy & Environmental Protection (DEEP). The contract, valued at $1,817,587.32, is for services related to the FDA's Mammography Quality Standards Act (MQSA) program, which regulates mammography facilities. The contract has a period of performance ending on September 29, 2027 and is a firm fixed-price contract. The contract was not set aside for any specific...
The Washington State Department of Health was awarded a $1,177,784.02 firm-fixed-price contract by the Food and Drug Administration (FDA) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This is a sole-source award, as the contract is restricted to state organizations possessing the legal authority to access commercial establishments for regulatory inspections and experienced...
The Food and Drug Administration (FDA) awarded a $483,881.81 firm-fixed-price definitive contract to the Arkansas Department of Health (ADH) for the "ARKANSAS MQSA INSPECTION CONTRACT". This contract supports inspections of certified non-federal mammography facilities in Arkansas to ensure compliance with the Mammography Quality Standards Act (MQSA). ADH was selected as the sole source provider for this requirement due to its legal authority under state law to access commercial...
This contract was awarded by the Food and Drug Administration (FDA) to the Arizona Department of Health Services (ADHS), a state government entity, to conduct inspections of certified non-federal mammography facilities in Arizona. The contract, valued at $1,911,936.08, is a definitive, firm-fixed-price contract with a period of performance through March 29, 2028. The original solicitation was a sole-source procurement, as the inspections require legal authority under state law and experience...
<p>The Food and Drug Administration (FDA) awarded a firm fixed price definitive contract to the City of New York, through its New York City Department of Health and Mental Hygiene Division (Health Dept), for the implementation of the Mammography Quality Standards Act (MQSA) in New York City. The contract, valued at $3,676,553.75, has an ultimate completion date of March 29, 2028. The contract was awarded on September 22, 2022 and does not have a set-aside designation.</p>
This is a sole source, definitive contract awarded by the Food and Drug Administration (FDA) to the Pennsylvania Department of Environmental Protection (DEP) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has a ceiling value of $3,364,865.52 and a period of performance through September 19, 2026. The contract was awarded without a set-aside designation. It...